Literature DB >> 7362716

Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.

J D Stephens, S O Banim, R A Spurrell.   

Abstract

To examine possible augmentation of the effects of isosorbide dinitrate by salbutamol, haemodynamic measurements were made in 10 patients with severe chronic congestive cardiac failure who received isosorbide dinitrate 2.5 to 25 mg sublingually and salbutamol 4 to 12 mg orally, alone and in combination. Isosorbide dinitrate reduced mean left ventricular filling pressure from 29 to 18 mmHg and increased mean cardiac index from 1.7 to 2.0 1/min per m2, with no significant change in mean heart rate. Systemic arterial mean pressure fell from 85 to 72 mmHg. Salbutamol increased cardiac index from 1.8 to 2.2 1/min per m2. There was no significant change in left ventricular filling pressure, heart rate, or systemic arterial pressure. Compared with control, combined isosorbide dinitrate and salbutamol reduced left ventricular filling pressure from 27 to 19 mmHg and increased cardiac index from 1.8 to 2.7 1/min per m2, with no significant change in heart rate. Systemic arterial pressure fell from 82 to 75 mmHg. The reduction in left ventricular filling pressure by combined treatment was similar to that produced by isosorbide dinitrate alone, but the increase in cardiac index was significantly greater than that produced either by isosorbide dinitrate alone or salbutamol alone. Combined sublingual isosorbide dinitrate and oral salbutamol have an additive effect in improving left ventricular performance in patients with severe chronic congestive cardiac failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362716      PMCID: PMC482266          DOI: 10.1136/hrt.43.2.220

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.

Authors:  R Gray; K Chatterjee; J K Vyden; W Ganz; J S Forrester; H J Swan
Journal:  Am Heart J       Date:  1975-09       Impact factor: 4.749

Review 2.  Measurement of blood flow by thermodilution.

Authors:  W Ganz; H J Swan
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

3.  Haemodynamic effects of salbutamol in patients needing circulatory support after open-heart surgery.

Authors:  S D Wyse; D G Gibson; M A Branthwaite
Journal:  Br Med J       Date:  1974-08-24

4.  Improved left ventricular function during nitroprusside infusion in acute myocardial infarction.

Authors:  J A Franciosa; C J Limas; N H Guiha; E Rodriguera; J N Cohn
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

5.  Effect of salbutamol on the peripheral circulation in man.

Authors:  T T Zsotér; S W Epstein
Journal:  Chest       Date:  1973-10       Impact factor: 9.410

6.  Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.

Authors:  J Beregovich; C Bianchi; S Rubler; E Lomnitz; N Cagin; B Levitt
Journal:  Am Heart J       Date:  1974-05       Impact factor: 4.749

7.  Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction.

Authors:  K Chatterjee; W W Parmley; W Ganz; J Forrester; P Walinsky; C Crexells; H J Swan
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

8.  Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.

Authors:  D O Williams; W J Bommer; R R Miller; E A Amsterdam; D T Mason
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

9.  Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

Authors:  V A Cullum; J B Farmer; D Jack; G P Levy
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

10.  Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs.

Authors:  M J Daly; J B Farmer; G P Levy
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

View more
  1 in total

Review 1.  Combination of positive inotropic and vasodilating substances in congestive heart failure.

Authors:  I Cantelli; D Bracchetti
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.